Active research and development by leading players as well as small innovative organizations
are expected to boost growth of the immune-oncology drugs market
According to the World Health Organization (WHO), cancer was responsible for 8.8 million
deaths in 2015. Owing to benefits associated with these therapies, the leading players are
actively investing in research and development into this treatment category through various
collaborations and individual research studies. For instance, EMD Serono is involved in research
and development of immune-oncology drugs and has a few drugs in pipeline such as M7824
(investigational) bifunctional immunotherapy. In 2015, Merck & Co., a leading drug
manufacturer and MD Anderson Cancer Center entered into a strategic clinical research
collaboration for formers drug Keytruda (Pembrolizumab). Celsee Diagnostics and IncellDx
announced an immuno-oncology research agreement in 2017. Bristol-Myers Squibb is developing
immuno-oncology approaches for treatment of colorectal cancer, lung cancer, melanoma, liver
cancer, lymphoma, multiple myeloma, and others. Amgen, Inc. is actively involved in immune-
oncology research and the company launched an immunotherapy collaboration with Kite Pharma
to develop and commercialize chimeric antigen receptor (CAR) T cells in 2015.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1271
Some major players operating in the immuno-oncology drugs market include Amgen, Inc.
AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck &
Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG, AbbVie, Inc.,
Pfizer Inc., Sanofi S.A., EMD Serono, Inc., Gilead Sciences Inc., Prometheus Therapeutics &
Diagnostics, Aduro BioTech, Galena Biopharma, Bavarian Nordic, Celldex Therapeutics,
ImmunoCellular Therapeutics, and Incyte.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200